Dr Kaustuv Nayak received his B.Sc. and M.Sc. from Loyola College, Chennai. During his Ph.D. and Post-Doctoral Research work at Tuberculosis Research Centre (I.C.M.R), Chennaihestudiedvarious facets of Immunopathology of HIV-Tb co-infection with/without Anti tuberculosis&Anti-Retroviral therapy. He identified laboratory predictors of Immune Reconstruction Inflammatory Syndrome in TB/HIV co-infected patients. Dr Nayak joined ICGEB-Emory Vaccine Centre, International Centre for Genetic Engineering and Biotechnology (ICGEB), New Delhi as Research Scientist in the year 2012 and specialises inthe area of Infectious Disease Immunology.

His lab is an unique partnership between Emory Vaccine Centre, USA and ICGEB, India with the goal of understanding human immunity to infectious diseases of public health importance to India. His role in the lab entails in basic and translational research on TB, Dengue and chikungunya. His primary scientific goal is to understand and identify key factors involved in the maintenance of T&B immunity after infection. Considering India’s burden of Dengue and chikungunya, very little is known about the immune response elicited and the epitopes that are recognized for a robust immune response. He is using classical epitope mapping technique and analysing the ex-vivo effector & memory T&B cell responses from patients.He has many peer-reviewed publications to his credit and multiple travel grants to present his research work at various international congresses. He is a passionate photographer and traveller.